Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET.
Join this free webinar to learn about the key benefits and latest innovations to be aware of in AI and lab automation.
Maria Gil will discuss how the future of healthcare is data-driven and is being bolstered by analytics and powered by AI and automation. Hear from Gil to understand why it’s these technologies that hold the promise of revolutionising tomorrow’s care.
Jeremy Skillington will speak about how Poolbeg Pharma has yielded significant breakthroughs in its AI-led programmes targeting influenza and RSV using human challenge trial data.
In her presentation, Helen Liu-Mayo answers the question: What is the true opportunity with ML and AI in biotech? Hear from Liu-Mayo on how to pick an AI focus, measure progress and impact to date, and lessons learned.
In his presentation, Nathan Buchbinder will highlight the critical role that an AI-enabled enterprise platform plays in realising the full value of data-driven drug discovery and development. He will walk through the three critical functions that Proscia’s enterprise pathology platform, Concentriq, performs in putting computational solutions into practice.
What you will learn:
- What are the benefits of AI in drug discovery?
- How can this technology improve time to market, increase cost savings and drive efficiencies?
- What are the key objectives to uptake and how can they be overcome?
- What are the benefits of remote labs?
An audience Q&A session with the presenters will follow the webinar presentation.
